Becton Dickinson & Co (BDX) stock
BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3017% above fair value
$215.71+1.19 (+0.55%)
Close on Nov 12, 2026Market cap $58.76BP/E 65.2Yield 1.93%
Becton Dickinson operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Becton Dickinson's operating cash flow for the twelve months ending Jun 30, 2026 was $3.96B, up 43.5% year over year. For fiscal 2025 it was $3.43B, down 10.8% from the year before. Over ten years it grew 7.1% a year on average. The highest annual figure on record is $4.13B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.43B | -10.8% |
| FY2024 | Sep 30, 2024 | $3.84B | +28.6% |
| FY2023 | Sep 30, 2023 | $2.99B | +21.0% |
| FY2022 | Sep 30, 2022 | $2.47B | -40.1% |
| FY2021 | Sep 30, 2021 | $4.13B | +40.5% |
| FY2020 | Sep 30, 2020 | $2.94B | -11.8% |
| FY2019 | Sep 30, 2019 | $3.33B | +16.2% |
| FY2018 | Sep 30, 2018 | $2.87B | +12.4% |
| FY2017 | Sep 30, 2017 | $2.55B | -0.4% |
| FY2016 | Sep 30, 2016 | $2.56B | +47.9% |
| FY2015 | Sep 30, 2015 | $1.73B | -0.9% |
| FY2014 | Sep 30, 2014 | $1.75B | +1.7% |
| FY2013 | Sep 30, 2013 | $1.72B | +1.4% |
| FY2012 | Sep 30, 2012 | $1.69B | +3.4% |
| FY2011 | Sep 30, 2011 | $1.64B | +3.2% |
| FY2010 | Sep 30, 2010 | $1.59B | -4.3% |
| FY2009 | Sep 30, 2009 | $1.66B | +2.5% |
| FY2008 | Sep 30, 2008 | $1.62B | +31.5% |
| FY2007 | Sep 30, 2007 | $1.23B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $776.00M | -28.7% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $671.00M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $657.00M | -5.2% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $1.85B | +57.2% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $1.09B | -16.0% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$204.00M | -139.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $693.00M | -18.9% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $1.18B | -11.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $1.30B | +20.0% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $514.00M | +177.8% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $855.00M | +114.3% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $1.33B | +36.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $1.08B | +59.4% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $185.00M | -36.2% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $399.00M | -24.7% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $973.00M | +15.7% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $678.00M | +20.2% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $290.00M | -75.6% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $530.00M | -65.4% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $841.00M | -4.3% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $564.00M | -34.6% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $1.19B | +146.0% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $1.53B | +115.0% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $879.00M | -35.9% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $862.00M | -7.5% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $483.00M | -38.2% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $713.00M | +191.0% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $1.37B | +5.0% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $932.00M | +72.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $782.00M | +12.2% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $245.00M | -23.4% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $1.31B | +16.0% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $542.00M | +41.1% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $697.00M | -3.9% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $320.00M | +1.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $1.13B | +59.7% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $384.00M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $725.00M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $315.00M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $705.00M | – |
See a number that looks wrong?